Home - Medicinapersonalizada
.
.
.
.
.
Video gallery
European Digital Innovation Hub Navarra
European Digital Innovation Hub Navarra – IRIS chaired by Government of Navarre and selected by the European Commission to be part of the first network of European Digital Innovation Hubs (EDIHs), acts as a catalyst for digital transformation, offering specialised services in Personalised Precision Medicine, High Performance Computing and Artificial Intelligence to companies and public entities at regional, national and European level.
IRIS’ Service Catalogue:
Latest news
Genome sequencing identifies advanced hepatocarcinoma patients with worse prognosis
The Clinical and Molecular Hepatology Journal echoes the research carried out by Dr. Miguel Sogbe, a fifth-year resident in Internal Medicine at the Clínica Universidad de Navarra, which highlights the prognostic value of sequencing the whole genome at low depth of circulating tumor DNA.
Regional Minister Fanlo highlights Navarre's capacity and leadership in personalised medicine after visiting the novel Navarrabiomed facilities
During the day, the Minister chaired a meeting with research staff from the Genomic Medicine Unit in which she was able to learn about the progress of the NAGEN Program projects that the centre has been developing since 2016 and the Infrastructure for Precision Medicine associated with Science and Technology (IMPaCT), which is coordinated nationally by the Carlos III Institute of Health (ISCIII) and centralised in Navarre at Navarrabiomed.
4,000 people will participate in a study to learn why we get sick, improve prevention and move towards personalized precision medicine.
The Regional Minister of Health, Fernando Domínguez, presied today the presentation of the IMPaCT Cohort study at the Lezkairu health centre. This study aims to carry out an exhaustive health study of 200,000 people representative of the Spanish population over the next 20 years, 4,000 in Navarra, in order to better understand the origin of the main diseases, thus helping to prevent and treat them, promoting personalised and precision medicine. The event was also attended by Patricia Palacio and Óscar Lecea, principal investigator and collaborator of the study in Navarre, respectively, and the Primary Care manager, Susana Miranda.